MAPS International MDMA-assisted Therapy Training Program
A collaboration between MAPS and the Clinical Psychedelic Lab at Monash University, this training program prepares mental healthcare professionals to support MDMA-assisted psychotherapy for PTSD. It combines online learning with a week-long in-person residential intensive and is limited to 65 trainees.
Course Overview
The MAPS International MDMA-assisted Therapy Training Program is a collaborative training offered by the Multidisciplinary Association for Psychedelic Studies (MAPS) and the Clinical Psychedelic Lab at Monash University. It is designed for qualified mental healthcare professionals seeking training in the safe and effective delivery of MDMA-assisted psychotherapy for PTSD. The program includes live presentations, video case presentations, discussions, scenario-based learning, self-reflection activities, group activities, online coursework, and creative projects. It covers fundamental processes, therapeutic alliances, and personal growth practices relevant to investigational MDMA-assisted therapy. The course runs over approximately 90 hours and combines asynchronous online material, live online seminars, and a 7-day residential intensive. The source states that the course is not currently being offered.
Who is this for?
Qualified and experienced mental healthcare professionals, including Authorised Prescribers and their teams, and therapists involved in ongoing or upcoming clinical trials.
Prerequisites
Qualified and experienced mental healthcare professionals; the source does not specify additional entry requirements.
Course Details
- Price$7,650
- FormatHybrid
- Lifecycle statusNo New Dates
- SkillsPsychotherapyMDMA-Assisted TherapyMDMA-assisted psychotherapyPTSD treatment supporttherapeutic alliancescenario-based learningself-reflectiongroup facilitationonline clinical learning
- Categories
You will be redirected to the provider's website
Related Courses
View all coursesCertificate in Psychedelic-Assisted Therapies & Research | CIISCIIS LogoCIIS Logo
A 12-month certificate in psychedelic-assisted therapies and research offered by CIIS. The program includes hybrid or online study and covers clinical competencies, research, cultural context, and ethical practice.
FDA On MDMA-Assisted Psychotherapy
This page discusses the FDA's rejection of MDMA-assisted psychotherapy and summarizes the rationale given for further research. It also reviews MDMA's history, reported therapeutic uses, and MAPS' response to the decision.
Automated status check: No valid upcoming cohort date found on the source page (checked 2026-04-12).
MDMA-Assisted Therapy: FDA Update
An update on the FDA status of MDMA-assisted therapy and what to expect going forward. The page indicates a 3-month duration, but provides no further course details.
Automated status check: No valid upcoming cohort date found on the source page (checked 2026-04-12).